Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Product Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06607003
What this trial is testing

Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 300
Early research (Phase 1)Study completedNCT02581696
What this trial is testing

The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers

Who this might be right for
Peptic Ulcer
Boryung Pharmaceutical Co., Ltd 24
Testing effectiveness (Phase 2)Study completedNCT00050076
What this trial is testing

Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.

Who this might be right for
Congestive Heart Failure
Takeda 204
Testing effectiveness (Phase 2)UnknownNCT02917291
What this trial is testing

Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury

Who this might be right for
Acute Traumatic Spinal Cord Injury
Ferrer Internacional S.A. 48
Early research (Phase 1)Ended earlyNCT04586920
What this trial is testing

LY3509754 in Healthy Non-Japanese and Japanese Participants

Who this might be right for
Healthy
Eli Lilly and Company 104
Early research (Phase 1)Active Not RecruitingNCT06618079
What this trial is testing

Drug-Drug Interaction Study Between HUC2-565-A and HUC2-565-B

Who this might be right for
Hypertension
Huons Co., Ltd. 46
Testing effectiveness (Phase 2)Looking for participantsNCT04648046
What this trial is testing

CAR-T Cells for HIV Infection

Who this might be right for
HIV Infections
Steven Deeks 18
Testing effectiveness (Phase 2)Ended earlyNCT00299390
What this trial is testing

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Bayer 10
Early research (Phase 1)UnknownNCT04740398
What this trial is testing

CBP-1008 in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Coherent Biopharma (Suzhou) Co., Ltd. 143
Early research (Phase 1)Active Not RecruitingNCT03773393
What this trial is testing

A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF)

Who this might be right for
Bone Marrow Disease
Cellenkos, Inc. 18
Early research (Phase 1)UnknownNCT05829057
What this trial is testing

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

Who this might be right for
Esophagus CancerBladder CancerLiver Cancer+2 more
Zhejiang University 10
Testing effectiveness (Phase 2)UnknownNCT06019936
What this trial is testing

A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in DILI Subjects

Who this might be right for
Drug-Induced Liver InjuryCholestatic Liver InjuryMixed Liver Injury
Xi'An Aolitai Pharmaceutical Technology Co Ltd 80
Early research (Phase 1)Study completedNCT04015232
What this trial is testing

Comparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.

Who this might be right for
ImmunogenicityHealthy Volunteers
Intas Pharmaceuticals, Ltd. 200
Early research (Phase 1)Study completedNCT02967159
What this trial is testing

Evaluate the Disposition of Drug in Body and Safety After Administration of Single Inhaled Doses of Drugs Abediterol and AZD7594 Administered Alone, in Fixed Dose Combination and in Free Combination Using the Dry Powder Inhaler in Healthy Male Participants

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)Asthma
AstraZeneca 14
Large-scale testing (Phase 3)Looking for participantsNCT07185997
What this trial is testing

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Who this might be right for
Non-Small-Cell Lung CancerMetastatic Non-Small-Cell Lung CancerAdvanced Non-Small-Cell Lung Cancer+3 more
ArriVent BioPharma, Inc.
Testing effectiveness (Phase 2)Study completedNCT01999582
What this trial is testing

Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on Hemodialysis

Who this might be right for
AnemiaKidney Failure, Chronic
Celgene 50
Large-scale testing (Phase 3)UnknownNCT04421534
What this trial is testing

Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19

Who this might be right for
COVID-19
Cairo University 150
Testing effectiveness (Phase 2)Study completedNCT04044001
What this trial is testing

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)

Who this might be right for
Pulmonary TuberculosesOther Specified Pulmonary Tuberculosis
Michael Hoelscher 78
Early research (Phase 1)Study completedNCT00001044
What this trial is testing

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Testing effectiveness (Phase 2)Study completedNCT00967902
What this trial is testing

Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent

Who this might be right for
Coronary Artery Lesions
OrbusNeich 180
Next Page
480